Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG NPP709 Syrup
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG NPP709 Syrup in Acute Upper Respiratory Tract Infection and Chronic Inflammatory Bronchitis Patients: Double Blinded, Randomized, Active Drug Comparative, Parallel Designed, Multi-centered, Phase III Study
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
This PHASE3 trial investigates Acute Upper Respiratory Tract Infections and Bronchitis and is currently completed. Ahn-Gook Pharmaceuticals Co.,Ltd leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Ewha Womans University
- Hanyang University
- Inha University Hospital
- Konkuk University Medical Center
- Kyunghee University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .